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LETTERS TO THE EDITOR 
Identification of Patent Pot-amen Ovale 
Permitting Paradoxic Embolism 
In a recent issue of the Murnal, Hausmann ,et al. (1) reported that 
severe contrast shunting and wide opening of the patent foramen’ovrde 
revealed a hii sensitivity and high we&city for identification of 
patients with ischemic arterial events wnsidered due to paradoxic 
emholism. 
ln my view, a weakness of this study lies in the composition of the 
control group (patients with no history of arterki ischemic evenk and 
a patent foramen wale as ouly an incidental findiug during kansesuph- 
ageal eebomrdiography). Given the high prevalence of patent foramen 
ovale, it is not wnceivable that only 27 patienk with these character- 
istics underwent kansewphageaJ echocardiogmphy during a time 
periodofalmost5yearsinsuchalargehospitalastheHannover 
Medical School. Therefore, some umpwified criteria might have 
intluenced the selection of this “controP group (i.e., the method of 
selecdng 27 subjeas from a presmwbly much larger pool of pat&k). 
lids dassic pitfaIl (2,3) may render comparison between the d&rent 
groups valueless and cast doubt on the excellent speciscity reported for 
ident6cation of a patent foramen wale that had probably allowed 
paradoxic embolism. This test sboukl therefore be challenged for ik 
spe&city in a much broader range of patients without arterial 
iwhemic evenk before ik optimistic introduction into medical prac- 
tice. 
JOHANN REISINGER, MD 
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Tmnsesophageal edtocardiography is a semi-invasive technique asso- 
dated with some diswmfort for the patient and a minor but definite 
ris& (1). Transesophageal w shotdd therefore be re- 
stricted to patients with a clinic4 indiition for performanw of this 
test (2). Estawkhing a wntrol group of patients undergeing a semi- 
imasivedmgwsucprowdureintheansenceofsigmgwntneatt 
disease repmsenk a chaiienge. 
ToeskbRshawntrrdgwupforthepmsentstudy(3),sewraiskict 
exdwionuiteriahadtobe~l)Gtdypatiettktmdergoing 
~WithM#malhWIk(~UdUiUUd 
wereseleued2)Patienkwitbahktoryofmterial 
isdIemkevewshad 
1817 
subgroup of patients with a patent foramen ovale could be included as 
the control group. Thus, 27 patienk fulfilled all criteria for the wntrd 
gOUp; the&? patients rqKeS&Xt -1% Of ail patients studied by 
tramesophageal echocardiography during this time period at our 
institution. 
We therefore do net agree with Reisinger that there must have 
been other selection criteria than those mentioned to explain the smag 
sire of the control group. Finally, we think that the selection of the 
wntrol patients had no intluence on the findings of our study. 
DIRK HAUSMANN, MD 
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Traasesophageal Echocardiography: 
Additional IBiagnostic and Therapeutic Role 
in Critically Ill Patients? 
In a recent israte of the Journal Heidenreich et al (1) emphrbed the 
diuiGaysignificantanl-of 
tothedirlgmkandsu~t 
cliticauyillpatienk.Tllequestioo~astowhether-- 
ogmpityolfersadditb4infonnationlwdingtodmngwiutherapy 
ando+mmlewith~totbe~andwmmordyuse4liwBsive 
premuremonitoringandcirdiacoutput-Relevautdata 
relatingitemodymu&varial&drkinedbyckkicalpuMummyarteay 
catbetefizathWerelr&hginthestdybyHeiietaL(1). 
Recently,WedewibedaMmspe&eadysis0ftnweqbgd 
edtocardiOgraphicinves@ti0nsduringalimitedperi0diol~uitieal 
carepatieUkinageUerdintemiveareUnit(2).Thesame6ndiogsrro 
thoseqmtedby-ietal.werefoundino4Kstudy.wiitla 
44%cbngeinttwapyafterbans@q@~ 
pelfOrfUedinpa~ktitha~al7erycat&eter.~ 
dlangesvariedinhot!lcardiacand~patien&fromadditional 
lzo8oii~to~ntofioodilasaytherapy. 
